Clinical Trial

Yoga-based, Movement Therapy Device as Noninvasive Glymphatic Clearance Augmentation in Alzheimer's Disease.

Study acronym: ReGlyde
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 10, 2025 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
This clinical trial evaluates a yoga-based intervention delivered through a powered therapeutic device designed to guide breathing and body movements. Building on evidence that mind-body practices may promote healthy aging, cognitive function, and glymphatic flow, the study uses physiological measurements, including fNIRS and wearable sensors, to investigate mechanisms and potential benefits in individuals at risk for Alzheimer's disease.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-15; most recent amendment 2025-07-07.
Trial Details
NCT Number NCT06989242
Lead Sponsor CIATRIX, INC.
Collaborators: University of Oulu
Conditions Alzheimer Disease, Mild Cognitive Impairment (MCI)
Enrollment 60 participants
Start Date 2025-07-01
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-10